|
|
|
|
Laevolac syrup |
> Products
> Laevolac syrup
|
|
|
 |
|
 |
|
| Name of the Product |
Laevolac® |
| Effect&Efficacy |
Treatment of portal systemic encephalopathy (Chronic PSE) |
| Active substance |
Lactulose |
| Pharmaceutical form |
Clear colourless to pale brownish yellow, viscous solution
|
| Classification |
Prescription drugs |
|
|
| Product characteristics |
|
ACCESSPHARM,INC. is developing the generic markets and expanding a business with a close collaboration of Fresenius Kabi in Austria.
ACCESSPHARM is supplying Laevolac syrup for the treatment of portal systemic encephalopathy(chronic PSE). |
|
|
